#871Medicine & HealthFront Page13 November 2025
Targeted IBD Therapy Proves Both Potent and Safer in Major Review
A major new analysis covering over 8,400 patients has confirmed that a novel class of drugs for Inflammatory Bowel Disease (IBD) is not only highly effective but also carries significantly fewer serious risks than placebo. These targeted therapies, known as IL-23p19 inhibitors, offer robust benefits across a wide range of patient groups, marking a significant advance in managing the chronic condition.
By Peng, Du, Miao, Shi, Li, Ge, Shen, Feng, Zhong, Gao, Chen
